Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - gene+therapy
High performance CRISPR-Cas12a system for combinatorial genetic manipulation
CRISPR-Cas12a allowing for simultaneous editing of multiple genes in mammalian cells Problem: CRISPR-based gene editing technique has revolutionized the field of molecular biology. While CRISPR-Cas9-based methods are effectively used for single-gene knockout, multiplex gene editing remains a major challenge. Unlike Cas9, Cas12a can be used for multigene...
Research Tools & Reagents
Photolinker to cage biological molecules
Turn Genes “On” or “Off” with Light Technology Overview: Dmochowski lab has designed a Ruthenium-based compound, RuBEP, that is a synthetically versatile photolinker. The photolinker can be tuned to be activated at a large range of visible and near-IR wavelengths, allowing for better tissue penetration and reducing toxicity...
Chemical Processes and Synthesis
© 2021. All Rights Reserved. Powered by